Outcome in critically ill medical patients treated with renal replacement therapy for acute renal failure: comparison between patients with and those without haematological malignancies

被引:91
|
作者
Benoit, DD
Hoste, EA
Depuydt, PO
Offner, FC
Lameire, NH
Vandewoude, KH
Dhondt, AW
Noens, LA
Decruyenaere, JM
机构
[1] Ghent Univ Hosp, Med Intens Care Unit, Dept Internal Med, B-9000 Ghent, Belgium
[2] Ghent Univ Hosp, Intens Care Med Div, B-9000 Ghent, Belgium
[3] Ghent Univ Hosp, Div Hematol, B-9000 Ghent, Belgium
[4] Ghent Univ Hosp, Div Renal, B-9000 Ghent, Belgium
关键词
acute renal failure; haematological malignancy; infection; intensive care unit; renal replacement therapy;
D O I
10.1093/ndt/gfh637
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
Background. Starting renal replacement therapy (RRT) for acute renal failure in critically ill patients with haematological malignancies is controversial because of the poor outcome and high costs. The aim of this study was to compare the outcome between critically ill medical patients with and without haematological malignancies who received RRT for acute renal failure. Methods. We retrospectively collected data on all consecutive patients who received RRT for acute renal failure at the Medical Intensive Care Unit (ICU) of a University Hospital between 1997 and 2002, and assessed the impact of the presence of a haematological malignancy on the survival within 6 months after ICU admission by Cox proportional hazard models. Results. Fifty of the 222 (22.5%) consecutive patients with haematological malignancies admitted to the ICU over the study period received RRT for acute renal failure compared with 248 of the 4293 (5.8%) patients without haematological malignancies (P < 0.001). Among patients who received RRT, those with haematological malignancies had higher crude ICU (79.6 vs 55.7%, P=0.002) and in-hospital (83.7 vs 66.1%, P = 0.016) mortality rates, and a higher mortality at 6 months (86 vs 72%, P = 0.018) by Kaplan-Meier estimates compared with those without haematological malignancies. However, after adjustment for the severity of illness and the duration of hospitalization before ICU admission, haematological malignancy by itself was no longer associated with a higher risk of death (hazard ratio 1.04; 95% confidence interval, 0.73-1.54, P = 0.78). Conclusions. Medical ICU patients with haematological malignancies have a higher rate of occurrence of acute renal failure treated with RRT and a higher mortality, compared with those without haematological malignancies. However, the presence of a haematological malignancy by itself is not a reason to withhold RRT in medical ICU patients with acute renal failure.
引用
收藏
页码:552 / 558
页数:7
相关论文
共 50 条
  • [41] Critically ill patients and acute renal failure - Reply
    Uchino, S
    Kellum, JA
    Bellomo, R
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 295 (06): : 624 - 625
  • [42] CITRATE PHARMACOKINETCS IN ACUTE LIVER FAILURE CRITICALLY ILL PATIENTS RECEIVING CONTINUOUS RENAL REPLACEMENT THERAPY
    Thanapongsatorn, Peerapat
    Sirivongrangson, Phatadon
    Lumlertgul, Nuttha
    Peerapornratana, Sadudee
    Srisawat, Nattachai
    Chaijamorn, Weerachai
    NEPHROLOGY, 2020, 25 : 38 - 38
  • [43] The effect of continuous versus intermittent renal replacement therapy on the outcome of critically ill patients with acute renal failure (CONVINT): a prospective randomized controlled trial
    Joerg C Schefold
    Stephan von Haehling
    Rene Pschowski
    Thorsten Onno Bender
    Cathrin Berkmann
    Sophie Briegel
    Dietrich Hasper
    Achim Jörres
    Critical Care, 18
  • [44] The effect of continuous versus intermittent renal replacement therapy on the outcome of critically ill patients with acute renal failure (CONVINT): a prospective randomized controlled trial
    Schefold, Joerg C.
    von Haehling, Stephan
    Pschowski, Rene
    Bender, Thorsten Onno
    Berkmann, Cathrin
    Briegel, Sophie
    Hasper, Dietrich
    Joerres, Achim
    CRITICAL CARE, 2014, 18 (01):
  • [45] Survival of critically ill patients with haematological malignancies compared with patients without haematological malignancy
    R Pugh
    P Hampshire
    P Hajimichael
    Critical Care, 17 (Suppl 2):
  • [46] THREE MONTH PSYCHOLOGICAL, OUTCOME IN CRITICALLY ILL PATIENTS RECEIVING RENAL REPLACEMENT THERAPY
    Sharpe, K. A.
    Boyd, N.
    Burt, K.
    Paddle, J. J.
    INTENSIVE CARE MEDICINE, 2013, 39 : S441 - S441
  • [47] Outcome of critically ill patients with COVID-19 requiring renal replacement therapy
    Roedl, Kevin
    Braunsteiner, Josephine
    Jarczak, Dominik
    Kluge, Stefan
    Fischer, Marlene
    Wichmann, Dominic
    WIENER KLINISCHE WOCHENSCHRIFT, 2022, 134 (19-20) : 728 - 728
  • [48] AKI Treated with Renal Replacement Therapy in Critically Ill Patients with COVID-19
    Gupta, Shruti
    Coca, Steven G.
    Chan, Lili
    Melamed, Michal L.
    Brenner, Samantha K.
    Hayek, Salim S.
    Sutherland, Anne
    Puri, Sonika
    Srivastava, Anand
    Leonberg-Yoo, Amanda
    Shehata, Alexandre M.
    Flythe, Jennifer E.
    Rashidi, Arash
    Schenck, Edward J.
    Goyal, Nitender
    Hedayati, S. Susan
    Dy, Rajany
    Bansal, Anip
    Athavale, Ambarish
    Nguyen, H. Bryant
    Vijayan, Anitha
    Charytan, David M.
    Schulze, Carl E.
    Joo, Min J.
    Friedman, Allon N.
    Zhang, Jingjing
    Sosa, Marie Anne
    Judd, Eric
    Velez, Juan Carlos Q.
    Mallappallil, Mary
    Redfern, Roberta E.
    Bansal, Amar D.
    Neyra, Javier A.
    Liu, Kathleen D.
    Renaghan, Amanda D.
    Christov, Marta
    Molnar, Miklos Z.
    Sharma, Shreyak
    Kamal, Omer
    Boateng, Jeffery Owusu
    Short, Samuel A. P.
    Admon, Andrew J.
    Sise, Meghan E.
    Wang, Wei
    Parikh, Chirag R.
    Leaf, David E.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (01): : 161 - 176
  • [49] A primer on continuous renal replacement therapy for critically ill patients
    Joy, MS
    Matzke, GR
    Armstrong, DK
    Marx, MA
    Zarowitz, BJ
    ANNALS OF PHARMACOTHERAPY, 1998, 32 (03) : 362 - 375
  • [50] Acute renal failure in critically ill elderly patients: A reason to dispense with therapy?
    Muhl, E
    Hansen, M
    Bruch, HP
    LANGENBECKS ARCHIV FUR CHIRURGIE, 1996, : 522 - 523